Companies Cryptocurrencies
AMAG Pharmaceuticals Inc
AMAG Pharmaceuticals Inc
Exchange: Nasdaq Global Select
IPO Date: 11/06/1986
CEO: Mr. William Heiden
Biotechnology Healthcare 🔗
  • AMAG
  • price
  • market cap
  • changes
If you bought

shares of AMAG Pharmaceuticals Inc (AMAG) on
You would have made
Old Price $12 Current Price $12

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Waltham, Massachusetts and currently employs 467 full-time employees. The firm’s segment is the manufacture, development and commercialization of products and services for use in treating various conditions, with a focus on maternal health, anemia management and cancer supportive care. Its offerings focus on maternal health, anemia management and cancer supportive care, including its product, Makena (hydroxyprogesterone caproate injection); its product, Feraheme (ferumoxytol), for intravenous (IV) use, and MuGard Mucoadhesive Oral Wound Rinse. The company is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women. Makena is a drug indicated to reduce the risk of preterm birth in women pregnant with a single baby having a history of singleton spontaneous preterm birth.

Address: 1100 Winter St Waltham MASSACHUSETTS 02451

Stay updated.